activity
20212023
most citedA Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages

1 citations · 1 across the 4 of their papers we have counts for

collaborators
Showing 2021Show all

1 paper · 1 filter

stat.ME2021★ 1 cited

A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages

José L. Jiménez, Haiyan Zheng

Combination of several anti-cancer treatments has typically been presumed to have enhanced drug activity. Motivated by a real clinical trial, this paper considers phase I-II dose f…